Can Legend Biotech (LEGN) Turn Cell Therapy Scale Into Compounding Wealth?
Legend Biotech (NASDAQ:LEGN) presents a compelling equity thesis centered on transforming breakthrough oncology innovation into a high-margin, cash-generative cell therapy franchise.








